Summary
In a significant market movement during September 2023, Pencil Biosciences was the subject of a vc funding. The transaction achieved a gross valuation of £5,600,000. Leading the round was The Greater Manchester Loan Fund, UKI2S, Cheshire Life Science Fund, Martlet Capital, Octopus Ventures, Jonathan Milner, Northern Gritstone, o2h Ventures, SyndicateRoom’s Access Enterprise Investment Scheme.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
The Greater Manchester Loan Fund
Lead Investor / Acquirer
UKI2S
Lead Investor / Acquirer
Cheshire Life Science Fund
Lead Investor / Acquirer
Martlet Capital
Lead Investor / Acquirer
Octopus Ventures
Lead Investor / Acquirer
Jonathan Milner
Lead Investor / Acquirer
Northern Gritstone
Lead Investor / Acquirer
o2h Ventures
Lead Investor / Acquirer
SyndicateRoom’s Access Enterprise Investment Scheme
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in